Table 1.
Characteristics | n | Expression of SIRT1 | Expression of P-SIRT1 | ||||
---|---|---|---|---|---|---|---|
|
|
||||||
Positive | Negative | P value | Positive | Negative | P value | ||
Gender | 0.470 | 0.190 | |||||
Male | 32 | 18 | 14 | 10 | 22 | ||
Female | 18 | 12 | 6 | 9 | 9 | ||
Age (year) | 0.047 | 0.547 | |||||
< 60 | 21 | 16 | 5 | 9 | 12 | ||
≥ 60 | 29 | 14 | 15 | 10 | 19 | ||
Grade | 0.929 | 0.802 | |||||
High-Middle | 44 | 27 | 17 | 17 | 27 | ||
Low | 6 | 3 | 3 | 2 | 4 | ||
TNM stage | 0.018 | 0.405 | |||||
I-II | 30 | 14 | 16 | 10 | 20 | ||
III-IV | 20 | 16 | 4 | 9 | 11 | ||
LN metastasis | 0.341 | 0.285 | |||||
Absent | 31 | 17 | 14 | 10 | 21 | ||
Present | 19 | 13 | 6 | 9 | 10 | ||
Distant metastasis | NS | NS | |||||
Absent | 49 | 30 | 20 | 19 | 31 | ||
Present | 1 | 0 | 0 | 0 | 0 | ||
P53 mutation | 0.015 | 0.186 | |||||
Positive | 27 | 12 | 15 | 8 | 19 | ||
Negative | 23 | 18 | 5 | 11 | 12 | ||
Ki67 | 0.108 | 0.011 | |||||
Positive | 34 | 23 | 11 | 17 | 17 | ||
Negative | 16 | 7 | 9 | 2 | 14 |
P-SIRT1, Phospho-SIRT1; TNM, tumor node metastasis; LN, lymph node. The χ2 test or Fisher’s exact test was used to evaluate the association between SIRT1 or Phospho-SIRT1 expression and clinicopathological characteristics. P value < 0.05 was considered statistically significant.